We provide evidence that TSP1, produced by breast cancer cells, not only impairs functional tumor angiogenesis but also likely contributes to immune escape mechanisms, leading to metastasis and resistance to anti-PD-1 therapy in TNBC. Here, PDCD1 is linked to breast cancer.